Protecting America’s Health & Beauty Products From Bioterrorism

Monday, 11 Dec 2006 · Biotechnology

While most Americans are more worried about bombs than contaminated shampoo, experts agree the biggest threat to homeland safety looms within the food, medicine, and cosmetic industries. One manufacturer is now calling on the health and beauty industry to invoke tighter security measures against potential acts of bioterrorism before it's too late. (PRWeb Dec 11, 2006) Post Comment:Trackback URL: http://www.prweb.com/chachingpr.php/Q291cC1TaW5nLVRoaXItTWFnbi1NYWduLVplcm8= Read More »

Also:

Respirators Recommended by Leading Health Organizations Inadequate to Protect Users from H5N1 Avian Influenza Ppandemic, According to Respirator Distributor
Leading Pediatric Expert Supports Improvements in Child Health Products
Genesis Health Solutions, Inc. Enters Pre-Launch, Reveals Initial Product Offering
SCD Introduces Health Supplement SCD ProBiotica
Salugen Launches SpaGen, the Most Comprehensive DNA-Customized Nutritional Support Program for Spas and their Guests

del.icio.us · digg it · link

	Vitalea Science Expands its Scientific Advisory Board, Expands Microdosing to Environmental Fate and Metabolism of Agricultural and Industrial Chemicals
	Technology Transfer Firm Partners with Local Alternative Energy Venture to Speed Commercialization: Innovation Management Partners, LLC Invests in Cleveland-based CleanFlo Technologies, LLC to Accelerate Technology Commercialization in the Growth Market for Alternative Fuels
	The AEgis Technologies Group Announces the Release of the Microsoft Excel Add-in for acslXtreme
	Monebo Technologies Obtains FDA Clearance to Market the CardioBelt™ Wireless ECG System
	Five Japanese Pharmaceutical Companies License Ariadne Pathway Studio Enterprise
	Alaska's Natural/Wild Food, Beverage and Bio Products Join Together to Stage Marketplace for Restaurant, Grocery and Food Service Market Buyers
	Akaza Research, SemanticBits and Robert H. Lurie Comprehensive Cancer Center of Northwestern University Partner to Develop caBIG™ Clinical Trials Adverse Events Reporting System for NIH's National Cancer Institute
	Amorcyte Cardiac Cell Therapy Trial Completes Second of Four Phases
	Vitalea Science Announces Key Addition to its Scientific Advisory Board in Microdosing for Pediatric Pharmacology and HIV Research
	Arrowhead Publishers' New Study Reveals Trends in Pharmaceutical Clinical Trial Outsourcing to Emerging Markets

	Biotechnology
	Electronics
	General
	Graphic Design & Printing
	Industrial
	Information Technology
	Instrumentation
	Multimedia
	Nanotechnology
	Public Sector
	Robotics
	Semiconductors
	Telecommunications